查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1437516

羟嗪市场，按剂型、适应症类型、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Hydroxyzine Market, By Dosage Form, By Indication Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 289 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年羟嗪市场规模为2.133亿美元，2024年至2032年CAGR为5.5%。

羟嗪市场-市场动态

过敏盛行率的上升推动了市场的成长

在过去的几十年里，全世界过敏和相关疾病的发生率增加。由于多种原因，出现过敏反应的人数正在增加。例如，最新更新于 2022 年 4 月的《过敏事实和数据》指出，过敏是美国慢性病的第六大常见原因，每年影响近 5,000 万人。因此，该国过敏症盛行率很高，需要改进治疗方案。对此，IJERPH 2021 年 11 月发表的一篇论文指出，儘管过敏的确切原因尚不清楚，但遗传和环境因素对全球过敏性疾病的负担有很大影响。此外，根据几项研究，羟嗪可用于缓解过敏相关的搔痒。它是一种抗组织胺药，其作用是在发生过敏反应时防止身体产生称为组织胺的特定有机化合物。因此，越来越需要羟嗪来控制疾病负担。因此，目标族群显着的过敏负荷和羟嗪对过敏的治疗优势预计将推动市场扩张。

羟嗪市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 5.5% 左右的CAGR成长

根据剂型细分，片剂细分市场占据主导地位，并可能在预测期内保持其主导地位

根据适应症类型细分，异位性接触性皮肤炎细分市场预计将在预测期内占据最大的市场份额

按地区划分，北美是 2023 年的主要收入来源

羟嗪市场-細項分析：

全球羟嗪市场根据剂型、适应症类型和地区进行细分。

市场依剂型分为四大类：胶囊剂、锭剂、注射剂和糖浆剂。平板电脑市场在市场上占据主导地位，并可能在预测期内保持其主导地位。羟嗪等抗组织胺药物很快就从消化系统吸收，口服后 15 至 30 分钟开始显示临床效果。这些旨在减轻精神和神经疾病带来的压力和焦虑。它有助于手术前的睡眠。由于越来越多地使用片剂剂型来治疗过敏性疾病和焦虑，以及神经系统疾病盛行率的增加，该类别正在不断增长。

根据适应症类型，市场分为三类：荨麻疹、组织胺介导的搔痒症和异位性接触性皮肤炎。预计异位性接触性皮肤炎细分市场在预测期内将占据最大的市场份额。由于对羟嗪剂型的需求不断增长以及异位性皮肤炎的盛行率不断增加，市场收入增加。根据国际湿疹理事会 2022 年的数据，异位性皮肤炎非常普遍，影响高达 10% 的成人和 20% 的儿童。此外，在伤残调整生命年评估的皮肤病中，疾病负担排名第一，在非致命性疾病中排名第 15 位。

羟嗪市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。这些区域根据开展业务的国家进一步划分。预计北美将在 2023 年占据最大市场份额，并且由于特应性接触性皮肤炎的高发生率、完善的基础设施以及对焦虑和神经障碍的认识不断提高，预计在预测期内将继续保持相同的模式疗法，以及合约研究组织和製药公司之间合作的增加。根据CDC 的数据，2019 年至2021 年间，所有年龄层成年人接受精神健康照护的比例从19.2% 上升至21.6%，18 岁至44 岁之间的个人接受精神健康照护的比例从18.5% 上升至23.2%。此外，女性18 至 44 岁人群中，比男性更有可能接受心理健康护理。

羟嗪市场-竞争格局：

市场上主要的参与者有Alliance Pharma PLC、OAK PHARMS INC.、Teva Pharmaceutical Industries、Piramal Healthcare UK Limited、辉瑞公司、上海瑞正化学科技有限公司、Lupin Pharmaceuticals, Inc.、葛兰素史克公司、常州ComWin精细化学品有限公司、Impax Laboratories, Inc. 和诺华国际股份公司。这些参与者采取各种类型的策略来维持市场竞争力，例如产品发布、收购、扩张、批准、协议等。

最近的发展：

2022年12月，HPRA核准Brillpharma（爱尔兰）将盐酸羟嗪25毫克薄膜衣片商业化。这些拥有成人焦虑管理许可证。

目录

第一章：羟嗪市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 羟嗪市场片段（按剂型）
    • 按适应症类型分類的羟嗪市场片段
    • 按国家/地区分類的羟嗪市场片段
    • 按地区分類的羟嗪市场片段
  • 竞争洞察

第 3 章：羟嗪主要市场趋势

  • 羟嗪市场驱动因素
    • 市场驱动因素的影响分析
  • 羟嗪市场限制
    • 市场限制影响分析
  • 羟嗪市场机会
  • 羟嗪市场未来趋势

第 4 章：羟嗪产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：羟嗪市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：羟嗪市场格局

  • 2023 年羟嗪市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：羟嗪市场 - 按剂型

  • 概述
    • 按剂型分類的细分市场份额分析
    • 胶囊
    • 平板电脑
    • 注射
    • 糖浆

第 8 章：羟嗪市场 - 依适应症类型

  • 概述
    • 按指标类型分類的细分市场占有率分析
    • 荨麻疹
    • 组胺介导的搔痒
    • 异位性接触性皮肤炎

第 9 章：羟嗪市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美羟嗪主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模与预测（按剂型）
    • 北美市场规模与预测（按适应症类型）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲羟嗪主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按剂型）
    • 欧洲市场规模和预测（按指示类型）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区羟嗪主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按剂型）
    • 亚太地区市场规模与预测（依适应症类型）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲羟嗪主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按剂型）
    • 拉丁美洲市场规模与预测（按适应症类型）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲羟嗪主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按剂型）
    • 中东和非洲市场规模及预测（按适应症类型）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 10 章：主要供应商分析 - 羟嗪产业

  • 竞争仪表板
  • 公司简介
    • Alliance Pharma PLC
    • OAK PHARMS INC.
    • Teva Pharmaceutical Industries
    • Piramal Healthcare UK Limited
    • Pfizer Inc.
    • Shanghai Ruizheng Chemical Technology Co., Ltd
    • Lupin Pharmaceuticals, Inc.
    • GlaxoSmithKline plc
    • Changzhou ComWin Fine Chemicals Co., Ltd
    • Impax Laboratories, Inc.
    • Novartis International AG

第 11 章：360 度分析师视角

第 12 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2234

REPORT HIGHLIGHT

Hydroxyzine Market size was valued at USD 213.30 Million in 2023, expanding at a CAGR of 5.5% from 2024 to 2032.

Hydroxyzine is an N-alkylpiperazine that is piperzine in which the nitrogens atoms are substituted by 2-(2-hydroxyethoxy) ethyl and (4-chlorophenyl) (phenyl)methyl groups respectively. It has a role as a H1-receptor antagonist, an anxiolytic drug, a dermatologic drug, an antipruritic drug and an anticoronaviral agent. It is an N-alkylpiperazine, a hydroxyether and a member of monochlorobenzenes.

Hydroxyzine Market- Market Dynamics

The rising prevalence of allergies drives market growth

Over the past several decades, there has been an increase in the frequency of allergies and associated disorders worldwide. The number of people experiencing allergic reactions is increasing for several reasons. As an illustration, Allergy Facts and Figures, which was last updated in April 2022, states that allergies account for the sixth most common cause of chronic disease in the United States, affecting almost 50 million individuals annually. As a result, the nation has a high prevalence of allergies, necessitating improved treatment alternatives. In this regard, a paper published in November 2021 in IJERPH states that, even though the exact causes of allergies are unclear, hereditary and environmental factors contribute significantly to the global burden of allergic illnesses. Furthermore, hydroxyzine may be utilized to relieve allergy-related itching, according to several studies. It is an antihistamine that functions by preventing the body from producing particular organic compounds known as histamine when an allergic response occurs. Thus, there is a growing need for hydroxyzine to control the burden of illness. As a result, the target population's significant allergy load and hydroxyzine therapeutic advantages for allergies are anticipated to drive market expansion.

Hydroxyzine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.5% over the forecast period (2024-2032)

Based on dosage form segmentation, the tablets segment dominates the market and is likely to maintain its dominance during the forecast period

Based on indication type segmentation, the atopic contact dermatitis segment is expected to hold the largest market share during the forecast period

Based on region, North America was the leading revenue generator in 2023

Hydroxyzine Market- Segmentation Analysis:

The Global Hydroxyzine Market is segmented based on Dosage form, Indication type and Region.

The market is divided into four categories based on dosage form: capsules, tablets, injections, and syrup. The tablet segment dominates the market and is likely to maintain its dominance during the forecast period. Antihistamine medications such as hydroxyzine are quickly absorbed from the digestive system and start to show clinical effects 15 to 30 minutes after oral administration. These are intended to reduce stress and anxiety brought on by mental and neurological disorders. It facilitates sleep before surgery. The category is growing due to the increasing use of tablet dosage forms for the treatment of allergic illnesses and anxiety, as well as an increase in the prevalence of neurological disorders.

The market is divided into three categories based on indication type: urticaria, histamine-mediated pruritus and atopic contact dermatitis. The atopic contact dermatitis segment is expected to hold the largest market share during the forecast period. The market's revenue has increased as a result of the growing demand for hydroxyzine dosage forms and the increasing prevalence of atopic dermatitis. As per the International Eczema Council 2022, atopic dermatitis is highly prevalent, impacting up to 10% of adults and 20% of children. Furthermore, the illness burden is ranked first for skin conditions evaluated in disability-adjusted life years and 15th globally for nonfatal disorders.

Hydroxyzine Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to hold a maximum market share in 2023 and is expected to continue the same pattern during the forecast period due to the high frequency of atopic contact dermatitis, the availability of well-established infrastructure, the rising awareness of anxiety and nervous disorder therapies, and the rise in collaborations between contract research organizations and pharmaceutical corporations. According to the CDC, the proportion of people receiving mental health care went up from 19.2% to 21.6% for adults of all ages and from 18.5% to 23.2% for individuals between the ages of 18 and 44 between 2019 and 2021. Furthermore, women were more likely than males to undergo mental health care among people aged 18 to 44.

Hydroxyzine Market- Competitive Landscape:

The key players operating in the market are Alliance Pharma PLC, OAK PHARMS INC., Teva Pharmaceutical Industries, Piramal Healthcare UK Limited, Pfizer Inc., Shanghai Ruizheng Chemical Technology Co., Ltd, Lupin Pharmaceuticals, Inc., GlaxoSmithKline plc, Changzhou ComWin Fine Chemicals Co., Ltd, Impax Laboratories, Inc. and Novartis International AG. These players adopted various types of strategies to remain competitive in the market such as product launches, acquisitions, expansion, approvals, agreements and others.

Recent Developments:

In December 2022, the HPRA approved Brillpharma (Ireland) to commercialize Hydroxyzine hydrochloride 25 mg film-coated tablets. These have adult anxiety management licenses.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HYDROXYZINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Alliance Pharma PLC

OAK PHARMS INC.

Teva Pharmaceutical Industries

Piramal Healthcare UK Limited

Pfizer Inc.

Shanghai Ruizheng Chemical Technology Co., Ltd

Lupin Pharmaceuticals, Inc.

GlaxoSmithKline plc

Changzhou ComWin Fine Chemicals Co., Ltd

Impax Laboratories, Inc.

Novartis International AG

GLOBAL HYDROXYZINE MARKET, BY DOSAGE FORM- MARKET ANALYSIS, 2019 - 2032

  • Capsules
  • Tablets
  • Injections
  • Syrup

GLOBAL HYDROXYZINE MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

  • Urticaria
  • Histamine-Mediated Pruritus
  • Atopic Contact Dermatitis

GLOBAL HYDROXYZINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Hydroxyzine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Hydroxyzine Market Snippet by Dosage Form
    • 2.1.2. Hydroxyzine Market Snippet by Indication Type
    • 2.1.3. Hydroxyzine Market Snippet by Country
    • 2.1.4. Hydroxyzine Market Snippet by Region
  • 2.2. Competitive Insights

3. Hydroxyzine Key Market Trends

  • 3.1. Hydroxyzine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Hydroxyzine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Hydroxyzine Market Opportunities
  • 3.4. Hydroxyzine Market Future Trends

4. Hydroxyzine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Hydroxyzine Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Hydroxyzine Market Landscape

  • 6.1. Hydroxyzine Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Hydroxyzine Market - By Dosage Form

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Dosage Form, 2023 & 2032 (%)
    • 7.1.2. Capsules
    • 7.1.3. Tablets
    • 7.1.4. Injections
    • 7.1.5. Syrup

8. Hydroxyzine Market - By Indication Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Indication Type, 2023 & 2032 (%)
    • 8.1.2. Urticaria
    • 8.1.3. Histamine-Mediated Pruritus
    • 8.1.4. Atopic Contact Dermatitis

9. Hydroxyzine Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Hydroxyzine Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Hydroxyzine Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Hydroxyzine Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Hydroxyzine Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Hydroxyzine Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Hydroxyzine Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Alliance Pharma PLC
    • 10.2.2. OAK PHARMS INC.
    • 10.2.3. Teva Pharmaceutical Industries
    • 10.2.4. Piramal Healthcare UK Limited
    • 10.2.5. Pfizer Inc.
    • 10.2.6. Shanghai Ruizheng Chemical Technology Co., Ltd
    • 10.2.7. Lupin Pharmaceuticals, Inc.
    • 10.2.8. GlaxoSmithKline plc
    • 10.2.9. Changzhou ComWin Fine Chemicals Co., Ltd
    • 10.2.10. Impax Laboratories, Inc.
    • 10.2.11. Novartis International AG

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Hydroxyzine Market: Dosage Form Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Dosage Form
  • TABLE Global Hydroxyzine Market, by Dosage Form 2019-2032 (USD Million)
  • TABLE Hydroxyzine Market: Indication Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Indication Type
  • TABLE Global Hydroxyzine Market, by Indication Type 2019-2032 (USD Million)
  • TABLE Hydroxyzine Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Hydroxyzine Market, by Region 2019-2032 (USD Million)
  • TABLE North America Hydroxyzine Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Hydroxyzine Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE North America Hydroxyzine Market, by Indication Type, 2019-2032 (USD Million)
  • TABLE Europe Hydroxyzine Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Hydroxyzine Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE Europe Hydroxyzine Market, by Indication Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Hydroxyzine Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Hydroxyzine Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE Asia Pacific Hydroxyzine Market, by Indication Type, 2019-2032 (USD Million)
  • TABLE Latin America Hydroxyzine Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Hydroxyzine Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE Latin America Hydroxyzine Market, by Indication Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Hydroxyzine Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Hydroxyzine Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Hydroxyzine Market, by Indication Type, 2019-2032 (USD Million)